Subscribe for Anthem Biosciences Ltd IPO; Anand Rathi

IPO

Anand Rathi, Anthem Biosciences Ltd

Incorporated in 2006, Anthem Biosciences Ltd is a technology-led, innovation-focused Contract Research, Development, and Manufacturing Organization (CRDMO) offering end-to-end solutions across the entire drug discovery, development, and manufacturing value chain. The company is among a select group of Indian players with integrated capabilities spanning New Chemical Entities (NCEs) and New Biological Entities (NBEs) across the drug discovery, development, and commercial manufacturing value chain. The company is among the first few players in India to utilize flow chemistry, biotransformation (such as bio-catalysis and enzymatic processes), micellar technology, and other innovative manufacturing techniques and the only company in India that has a strong presence across small molecules and biologics (large molecules). Anthem Biosciences is one of 3 CRDMOs that possess technological capabilities in India across ADCs, RNAi, peptides, and oligonucleotides, which are among the fastest growing in the pharmaceutical industry.

Valuation and Outlook

We believe company has potential to continue to grow its revenue and profitability ratios compared to its peers. Hence, we give “SUBSCRIBE” rating for the issue.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Anthem Biosciences -110725 - anand